SISTO Armaturen S.A. Introduces Automated Multi-Port Valve to Revolutionize Pharmaceutical Production

SISTO Armaturen S.A. Introduces Automated Multi-Port Valve to Revolutionize Pharmaceutical Production

(IN BRIEF) SISTO Armaturen S.A., part of the KSB Group, has developed the SISTO-CM1300, an automated multi-port valve designed to optimize pharmaceutical production processes. This valve automates the switching of fluids in cleaning and sterilization processes, reducing the risk of contamination and errors, and enhancing safety and efficiency. The SISTO-CM1300 offers precise flow control, minimizes downtime, and improves the overall quality of pharmaceutical manufacturing.

(PRESS RELEASE) FRANKENTHAL, 14-Aug-2024 — /EuropaWire/ — Luxembourg-based SISTO Armaturen S.A., a subsidiary of the KSB Group, has developed an innovative automated multi-port valve, the SISTO-CM1300, designed specifically for a leading French pharmaceutical company involved in the production of immunosuppressive drugs. This cutting-edge valve is set to revolutionize the way pharmaceutical production plants handle the complex processes of cleaning and sterilization, known as CIP (Clean-In-Place) and SIP (Sterilize-In-Place).

In pharmaceutical manufacturing, ensuring the precise flow and switching of various fluids through production systems is critical. Traditionally, this has been managed through transfer panels, which require manual operations to switch between different fluids. However, this manual process can be time-consuming, poses risks of contamination, and can introduce errors that compromise fluid purity and production safety.

The manual switching process also involves ensuring that each branch pipe is tightly shut off, which is both labor-intensive and requires repeated checks before starting a CIP process. These challenges highlight the need for a more efficient and reliable solution.

To address these issues, SISTO Armaturen S.A. has introduced the SISTO-CM1300, a compact, flow-optimized multi-way block diaphragm valve. Equipped with pneumatic actuators and electronic position feedback units, this valve automates the switching process, optimizing and streamlining pharmaceutical production. The automation provided by this valve not only makes the process faster and safer but also significantly reduces the risk of errors, leading to higher product quality.

One of the key benefits of the SISTO-CM1300 valve is its ability to precisely control the flow to each individual pipe in the system, eliminating the need for manual connection changes by operating personnel. This ensures uninterrupted sub-processes, facilitates thorough flushing and cleaning of pipes, and ultimately prevents fluid contamination. The result is a more reliable and efficient production process, with minimal downtime and enhanced safety for employees during both production and maintenance.

The introduction of the SISTO-CM1300 represents a significant advancement in pharmaceutical manufacturing technology, offering a solution that improves the overall efficiency, safety, and quality of the production process.

Media Contact:

Sonja Ayasse
Tel.: +49 6233 86-3118

SOURCE: KSB SE & Co. KGaA